2021 West Oncology APP | Treatment Options for Elderly AML/MDS Patients Published 2021-10-04 Download video MP4 360p Recommendations 19:15 2021 West Oncology APP | Update on Myeloma 1:00:46 Triple Negative Breast Cancer Case Panel Discussion | 2022 Best of Breast Conference 43:25 Safety Considerations for the Development of Antibody Drug Conjugates 1:18:22 Seizures in Dogs and Cats || SEVN Webinar Series 01:32 Follow the Evidence 51:31 Dr. Deb Schrag discusses the PROSPECT Trial as part of this DocTalk 18:46 Approach to the Exam for Parkinson's Disease 54:15 Technological Competence as Caring in Nursing: An Interview with Theorist Rozzano Locsin 1:01:16 Is Curing Stage IV Gastric Cancer Possible? w/ Dr. Brian Badgwell 17:31 Total Neoadjuvant Therapy in Rectal Cancer in the Community Setting 1:36:57 A Look at the Invisible Symptoms of MS - August 9th, 2014 - with Brian Steingo, MD 20:23 How Long Do Chemotherapy Side Effects Last? All You Need to Know 56:48 Immunotherapy for Gastroesophageal Cancer 58:07 USRPT Presentation ASCA 2016 // Peter Andrew 51:14 Health Matters 2024: Brain Power - How Science Is Revolutionizing Cognitive Health 09:56 Statins Explained in 10 Minutes (by a cardiologist) 19:45 Anti Estrogen Therapy Symptom Management Similar videos 14:58 2021 West Oncology | Hematological Malignancies | Updates in Myelodysplastic Syndromes 02:01 Treatment Advances for Aging AML Patients 01:26 Updates in the treatment landscape of p53-mutated AML/MDS 55:01 Oncology Nurse Perspectives, Principles, and Practice in an Era of Innovative AML Therapies 03:37 The future of AML treatment 05:11 The frontline treatment strategy for newly diagnosed AML 01:05 Updates on KO-539 as a treatment for AML 1:39:23 Treating MDS: What to Expect from Treatment 01:32 MDS, inflammation and AML 01:09 Advice for MDS patients in the COVID-19 era 01:21 What is the future of AML treatment? #AML 01:54 New developments in AML treatment 02:00 Has AML Monitoring and Treatment Changed During COVID 19 01:39 IPSS-R vs IPSS-M for MDS 09:24 How could new treatment combinations improve outcomes in TP53 mutant AML? 01:37 Dr. Saunthararajah on Mechanisms of Resistance to 5-Azacytidine/Decitabine in MDS-AML 1:00:08 GYN Gynecologic and ovarian cancer BCOP 2021 More results